Literature DB >> 3883808

Role of prostaglandins in control of intestinal motility.

P Thor, J W Konturek, S J Konturek, J H Anderson.   

Abstract

Intestinal myoelectric activity was measured in four conscious dogs with implanted monopolar electrodes after administration of prostaglandins (PG) and indomethacin (Indo), a potent inhibitor of PG biosynthesis. PGE2 and PGI2 given intravenously caused a dose-dependent decrease in the frequency of the migrating myoelectric complex (MMC) in fasted dogs and in postprandial spike activity in fed animals. In contrast, PGF2 alpha interrupted the MMC and caused a fedlike pattern in fasted dogs and did not affect the postprandial spike activity. Similar effects were observed after intra-arterial infusion of PGs. PGE2 and PGI2 infused into the superior mesenteric artery caused a dose-dependent inhibition of the fasted and postprandial pattern of myoelectric activity of the small bowel, whereas PGF2 alpha blocked the MMC and increased spike activity. Indo injected in a single intravenous dose caused a significant reduction in the MMC interval, and Indo infused intravenously in a constant dose induced fedlike motility pattern in fasted dogs but had little effect on the postprandial activity in these animals. This study demonstrates that exogenous PGs of E and I series administered intravenously or intra-arterially inhibit intestinal motility, whereas PGF2 alpha has opposite effects. The finding that Indo increases intestinal motility indicates that endogenous PGs are important in the physiological control of intestinal motility.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3883808     DOI: 10.1152/ajpgi.1985.248.3.G353

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

Review 1.  Physiology and pharmacology of prostaglandins.

Authors:  S J Konturek; W Pawlik
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

2.  Endotoxin actions on myoelectric activity, transit, and neuropeptides in the gut. Role of nitric oxide.

Authors:  P M Hellström; A al-Saffar; T Ljung; E Theodorsson
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

3.  Effects of parenteral diclofenac sodium on upper gastrointestinal motility after food in man.

Authors:  G Bassotti; G Bucaneve; C Betti; L Patoia; E Baratta; V Maresca; M A Pelli; A Morelli; A Del Favero
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Associations between physical activity and susceptibility to cancer: possible mechanisms.

Authors:  R J Shephard; P N Shek
Journal:  Sports Med       Date:  1998-11       Impact factor: 11.136

5.  Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine.

Authors:  R C de Lisle; R Sewell; L Meldi
Journal:  Neurogastroenterol Motil       Date:  2009-10-08       Impact factor: 3.598

6.  The role and interactions of nitric oxide (NO), carbon monoxide (CO), and prostanoids in the pathogenesis of postoperative ileus in rats.

Authors:  R P Korolkiewicz; J Sein-Anand; J Ruczyński; P Rekowski; L Bieniaszewski; Z Chodorowski; J Petrusewicz; M Ujda; J Dabkowski; M Bitel; S Kato; K Takeuchi
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

7.  Inactivation of inducible nitric oxide synthase protects intestinal pacemaker cells from postoperative damage.

Authors:  Hiroe Yanagida; Kenton M Sanders; Sean M Ward
Journal:  J Physiol       Date:  2007-05-17       Impact factor: 5.182

8.  COX-2 dependent inflammation increases spinal Fos expression during rodent postoperative ileus.

Authors:  C Kreiss; L A Birder; S Kiss; M M VanBibber; A J Bauer
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

9.  Opioid and nonopioid analgesic drug effects on colon contractions in monkeys.

Authors:  A A Ferraz; V E Cowles; R E Condon; W J Schulte
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

10.  Rotavirus infection increases intestinal motility but not permeability at the onset of diarrhea.

Authors:  Claudia Istrate; Marie Hagbom; Elena Vikström; Karl-Eric Magnusson; Lennart Svensson
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.